Detalles de la búsqueda
1.
Adaptation of an R5 Simian-Human Immunodeficiency Virus Encoding an HIV Clade A Envelope with or without Ablation of Adaptive Host Immunity: Differential Selection of Viral Mutants.
J Virol
; 93(9)2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30760566
2.
Central Nervous System Inflammation and Infection during Early, Nonaccelerated Simian-Human Immunodeficiency Virus Infection in Rhesus Macaques.
J Virol
; 92(11)2018 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29563297
3.
Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge.
J Virol
; 92(2)2018 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29093095
4.
Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose.
Retrovirology
; 11: 8, 2014 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24444350
5.
Novel biopanning strategy to identify epitopes associated with vaccine protection.
J Virol
; 87(8): 4403-16, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23388727
6.
Live-virus exposure of vaccine-protected macaques alters the anti-HIV-1 antibody repertoire in the absence of viremia.
Retrovirology
; 10: 63, 2013 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-23800339
7.
Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges.
Front Immunol
; 13: 788619, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35273592
8.
Mucosal AIDS virus transmission is enhanced by antiviral IgG isolated early in infection.
AIDS
; 35(15): 2423-2432, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34402452
9.
Cooperation Between Systemic IgG1 and Mucosal Dimeric IgA2 Monoclonal Anti-HIV Env Antibodies: Passive Immunization Protects Indian Rhesus Macaques Against Mucosal SHIV Challenges.
Front Immunol
; 12: 705592, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34413855
10.
Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV Challenge.
Front Immunol
; 11: 626464, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33658998
11.
Quantitation of HLA proteins incorporated by human immunodeficiency virus type 1 and assessment of neutralizing activity of anti-HLA antibodies.
J Virol
; 82(1): 428-34, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17942547
12.
Lymphocytes upregulate CD36 in adipose tissue and liver.
Adipocyte
; 8(1): 154-163, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31035848
13.
Anti-HIV IgM protects against mucosal SHIV transmission.
AIDS
; 32(11): F5-F13, 2018 07 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-29762161
14.
Antibody-mediated immune exclusion of HIV.
Curr Opin HIV AIDS
; 12(3): 222-228, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28422786
15.
Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: complete protection of rhesus monkeys from mucosal SHIV challenge.
Vaccine
; 33(17): 2086-95, 2015 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-25769884
16.
Consistent subtype-specific anti-HIV type 1 T lymphocyte responses in Indian subjects recently infected with HIV type 1.
AIDS Res Hum Retroviruses
; 18(18): 1389-93, 2002 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-12487810
17.
Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virus.
Vaccine
; 32(48): 6527-36, 2014 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-25245933
18.
Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmission.
AIDS
; 27(9): F13-20, 2013 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23775002
19.
High-level, lasting antiviral immunity induced by a bimodal AIDS vaccine and boosted by live-virus exposure: prevention of viremia.
AIDS
; 26(2): 149-55, 2012 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-21941166
20.
No acquisition: a new ambition for HIV vaccine development?
Curr Opin Virol
; 1(4): 246-53, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22081778